NCT02281448View on ClinicalTrials.gov

Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Epilepsy
Interventions
DRUG

BIA 2-093

DRUG

Contraceptives, Oral, Combined

Trial Locations (1)

4045-457

BIAL - Portela & Cª, S.A., S. Mamede Do Coronado

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02281448 - Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. | Biotech Hunter | Biotech Hunter